NCT03642756 is a NA clinical trial of different intra-arterial catheter size in Catheters, sponsored by Seoul National University Hospital.

Who is sponsoring NCT03642756?

NCT03642756 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03642756?

Interventions in NCT03642756: different intra-arterial catheter size.

Is NCT03642756 still recruiting?

NCT03642756 is currently status unknown. Last updated 22 August 2018.

Last reviewed 2018-08-22 · How we verify

NCT03642756

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Different Intra-arterial Catheter Size on Frequency of Optimal Dynamic Response in Radial Arterial Waveform

Status unknown NA Last updated 22 August 2018

What this trial tests

NA trial testing different intra-arterial catheter size in Catheters in 366 participants. Status unknown.

Timeline

1 October 2018

Primary endpoint
1 October 2019

1 December 2019

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	366
Start date	1 October 2018
Primary completion	1 October 2019
Estimated completion	1 December 2019
Sites	1 location across South Korea

Drugs / interventions tested

different intra-arterial catheter size

Conditions studied

Catheters — all drugs for Catheters →

Sponsor

Seoul National University Hospital

Who can join

Adults 20 to 79, any sex, with Catheters. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to compare the effects of different intra-arterial catheter size on the frequency of optimal dynamic response in radial arterial waveform.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Intraarterial catheter diameter and dynamic response of arterial pressure monitoring system: a randomized controlled trial.
Oh H, Choe SH, Kim YJ, Yoon HK, et al · · 2022 · cited 7× · PMID 33527182 · DOI 10.1007/s10877-021-00663-7

Verify or expand the search:

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03642756 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 22 August 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03642756.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing